ClinicalTrials.gov
ClinicalTrials.gov Menu

Compassion Training and Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01776645
Recruitment Status : Completed
First Posted : January 28, 2013
Results First Posted : December 16, 2013
Last Update Posted : December 16, 2013
Sponsor:
Information provided by (Responsible Party):
Stanford University

Brief Summary:
The purpose of this study is to determine whether compassion training will improve the physical and psychological well-being of patients with chronic pain. The investigators also want to determine whether any benefit of compassion training in the patients "spreads" to significant others with whom the patient has a close relationship.

Condition or disease Intervention/treatment Phase
Chronic Pain Behavioral: Compassion Cultivation Training Course Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2013
Actual Primary Completion Date : May 2013
Actual Study Completion Date : May 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chronic Pain

Arm Intervention/treatment
Experimental: Compassion cultivation training Behavioral: Compassion Cultivation Training Course



Primary Outcome Measures :
  1. Change in Brief Pain Inventory [ Time Frame: Baseline and end of 9-week treatment protocol ]
    Intensity - pain severity as measured by a 0 to 10 visual analogue scale. 0 = no pain, 10 = worst pain imaginable

  2. Change in Chronic Pain Acceptance Questionnaire [ Time Frame: Baseline and end of 9-week treatment protocol ]

Secondary Outcome Measures :
  1. Change in Brief Pain Inventory [ Time Frame: Baseline to end of 9-week treatment protocol ]
    Interference score - Interference as measured by a 0 to 10 numerical rating scale. 0 = does not interfere, 10 = completely interferes


Other Outcome Measures:
  1. Change in Emotional Distress [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by the Hospital Anxiety and Depression Scale

  2. Change in Overall Health and Well-being [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by Ryff's psychological well-being scales

  3. Change in Compassion [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by Neff's Self-Compassion Scale

  4. Qualitative Measures [ Time Frame: Baseline and end of 9-week treatment protocol ]
    Qualitative analysis of interviews

  5. Change in Emotional Distress [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As Assessed by the PROMIS Anger Scale

  6. Change in Emotional Distress [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by the PROMIS Social Isolation Scale

  7. Change in Overall Health and Well-being [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by PROMIS Global Health Scale

  8. Change in Compassion [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by Compassionate Love Scale adapted for close other

  9. Change in Compassion [ Time Frame: Baseline and end of 9-week treatment protocol ]
    As assessed by Pommier's Compassion for Other's Scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 18+ and chronic pain for >6months
  2. Pain over the last month
  3. Ability to read, write, and converse in English
  4. If being treated for pain condition, then stable treatment regimen.

For significant others:

1)18 years of age or older 2)Ability to read, write, and converse in English

Exclusion Criteria:

For patients and significant others:

1)Current or history of a psychological disorder that would interfere with study procedures, at the discretion of the researcher.

For patients only:

  1. prior compassion meditation experience
  2. on going legal action or disability claim
  3. currently pregnant or planning to become pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01776645


Locations
United States, California
Stanford University School of Medicine
Palo Alto, California, United States, 94304
Sponsors and Collaborators
Stanford University

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01776645     History of Changes
Other Study ID Numbers: 25883
First Posted: January 28, 2013    Key Record Dates
Results First Posted: December 16, 2013
Last Update Posted: December 16, 2013
Last Verified: October 2013

Additional relevant MeSH terms:
Chronic Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms